dapoxetine has been researched along with Impotence in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 7 (63.64) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aquilina, JW; Bull, S; Dean, J; Giuliano, F; Hellstrom, WJ; McMahon, CG; Rivas, DA; Sharma, O; Tesfaye, F | 1 |
| Althof, SE; Aversa, A; Isidori, AM; Jannini, EA; Lenzi, A | 1 |
| Bastide, C; Bruyère, F; Droupy, S; Geoffroy, R; Guy, L; Huygues, E; Karsenty, G; Marcelli, F; Rigot, JM; Robin, G | 1 |
| Seftel, AD | 1 |
| Hu, T; Kang, M; Qu, X; Song, Q; Yang, L; Zhang, D; Zhao, Y | 1 |
| Bloodworth, BC; Ge, X; Koh, HL; Li, L; Low, MY | 1 |
| Althof, SE; Aquilina, JW; Bull, S; McMahon, CG; Porst, H; Rivas, DA; Sharlip, I; Tesfaye, F | 1 |
| Aquilina, JW; Dean, J; Klep, R | 1 |
| Wyllie, MG | 1 |
| Azam, U | 1 |
| Safarinejad, MR | 1 |
2 review(s) available for dapoxetine and Impotence
| Article | Year |
|---|---|
[Drugs for sexual medicine].
Topics: Alprostadil; Androgens; Benzylamines; Erectile Dysfunction; Female; Humans; Hypogonadism; Male; Naphthalenes; Phosphodiesterase 5 Inhibitors; Phytotherapy; Premature Ejaculation; Selective Serotonin Reuptake Inhibitors; Testosterone; Urological Agents; Vasodilator Agents; Yohimbine | 2013 |
Late-stage clinical development in lower urogenital targets: sexual dysfunction.
Topics: Alprostadil; Androgens; Benzylamines; Clinical Trials as Topic; Dopamine Agonists; Ejaculation; Erectile Dysfunction; Female; Humans; Male; Naphthalenes; Phosphodiesterase Inhibitors; Receptors, Dopamine D2; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunction, Physiological; Sexual Dysfunctions, Psychological; Surveys and Questionnaires; Treatment Outcome; Vasodilator Agents | 2006 |
3 trial(s) available for dapoxetine and Impotence
| Article | Year |
|---|---|
Efficacy and safety of dapoxetine in men with premature ejaculation and concomitant erectile dysfunction treated with a phosphodiesterase type 5 inhibitor: randomized, placebo-controlled, phase III study.
Topics: Adult; Aged; Benzylamines; Coitus; Double-Blind Method; Ejaculation; Erectile Dysfunction; Humans; Male; Middle Aged; Naphthalenes; Penile Erection; Phosphodiesterase 5 Inhibitors; Premature Ejaculation; Selective Serotonin Reuptake Inhibitors; Time Factors; Treatment Outcome; Young Adult | 2013 |
Baseline characteristics and treatment outcomes for men with acquired or lifelong premature ejaculation with mild or no erectile dysfunction: integrated analyses of two phase 3 dapoxetine trials.
Topics: Adult; Benzylamines; Dose-Response Relationship, Drug; Double-Blind Method; Ejaculation; Erectile Dysfunction; Humans; Male; Middle Aged; Naphthalenes; Patient Satisfaction; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunction, Physiological | 2010 |
Safety and efficacy of dapoxetine in the treatment of premature ejaculation: a double-blind, placebo-controlled, fixed-dose, randomized study.
Topics: Administration, Oral; Adult; Benzylamines; Confidence Intervals; Double-Blind Method; Erectile Dysfunction; Follow-Up Studies; Humans; Male; Middle Aged; Naphthalenes; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome | 2008 |
6 other study(ies) available for dapoxetine and Impotence
| Article | Year |
|---|---|
Which is first? The controversial issue of precedence in the treatment of male sexual dysfunctions.
Topics: Adult; Benzylamines; Comorbidity; Counseling; Critical Pathways; Drug Therapy, Combination; Ejaculation; Erectile Dysfunction; Hormone Replacement Therapy; Humans; Hypogonadism; Male; Middle Aged; Naphthalenes; Patient Selection; Penile Erection; Phosphodiesterase 5 Inhibitors; Premature Ejaculation; Selective Serotonin Reuptake Inhibitors; Sexual Behavior; Testosterone; Treatment Outcome | 2013 |
Re: Efficacy and safety of dapoxetine in men with premature ejaculation and concomitant erectile dysfunction treated with a phosphodiesterase type 5 inhibitor: randomized, placebo-controlled, phase III study.
Topics: Benzylamines; Erectile Dysfunction; Humans; Male; Naphthalenes; Penile Erection; Phosphodiesterase 5 Inhibitors; Premature Ejaculation; Selective Serotonin Reuptake Inhibitors | 2014 |
[Rapid screening and confirmation of illegally added anti- impotence preparations in health care products by high performance liquid chromatography-high resolution mass spectrometry].
Topics: Benzylamines; Chromatography, High Pressure Liquid; Drug Contamination; Erectile Dysfunction; Humans; Indole Alkaloids; Male; Mass Spectrometry; Naphthalenes; Sildenafil Citrate; Tadalafil; Vardenafil Dihydrochloride; Vasodilator Agents | 2015 |
Isolation and structural elucidation of dapoxetine as an adulterant in a health supplement used for sexual performance enhancement.
Topics: Benzylamines; Chemistry, Pharmaceutical; Dietary Supplements; Drug Contamination; Erectile Dysfunction; Humans; Magnetic Resonance Spectroscopy; Male; Mass Spectrometry; Naphthalenes; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunction, Physiological; Spectrometry, Mass, Electrospray Ionization; Spectrophotometry, Infrared; Spectrophotometry, Ultraviolet; Tandem Mass Spectrometry; Temperature | 2009 |
Counterfeit dapoxetine sold on the Internet contains undisclosed sildenafil.
Topics: Adult; Benzylamines; Chromatography, High Pressure Liquid; Counterfeit Drugs; Erectile Dysfunction; Humans; Internet; Male; Middle Aged; Naphthalenes; Phosphodiesterase 5 Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Young Adult | 2010 |
The era of ESSTIs is slowly approaching?
Topics: Benzylamines; Ejaculation; Erectile Dysfunction; Humans; Male; Membrane Glycoproteins; Membrane Transport Modulators; Membrane Transport Proteins; Naphthalenes; Nerve Tissue Proteins; Serotonin Plasma Membrane Transport Proteins | 2005 |